Flucytosine
-
Subject Areas on Research
- 5-fluorocytosine resistance is associated with hypermutation and alterations in capsule biosynthesis in Cryptococcus.
- A flucytosine-responsive Mbp1/Swi4-like protein, Mbs1, plays pleiotropic roles in antifungal drug resistance, stress response, and virulence of Cryptococcus neoformans.
- A novel mouse model of podocyte depletion.
- Antifungal serum concentration monitoring: an update.
- Antifungal treatment in pediatric patients.
- Antifungals in Clinical Use and the Pipeline.
- Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis.
- Augmenting podocyte injury promotes advanced diabetic kidney disease in Akita mice.
- Brain abscess caused by a variety of cladosporium trichoides.
- Candida meningitis in two children with severe combined immunodeficiency.
- Case 4: Weakness and Headaches in a 14-year-old Boy.
- Combined activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo in mice.
- Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis.
- Cryptococcal meningitis in patients with glioma: a report of two cases.
- Cryptococcal meningoencephalitis: time for action.
- Cryptococcemia.
- Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus neoformans Speciation.
- Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine.
- Cytosine deaminase MX cassettes as positive/negative selectable markers in Saccharomyces cerevisiae.
- Editorial Commentary: Life-saving Antimicrobial Drugs: What Are We Doing to Pricing and Availability?
- Efficiently killing a sugar-coated yeast.
- Fungal homoserine kinase (thr1Delta) mutants are attenuated in virulence and die rapidly upon threonine starvation and serum incubation.
- Fungal infection following renal transplantation.
- Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.
- Ocular penetration of 5-fluorocytosine.
- Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patients.
- Recovery from disseminated candidiasis in a premature neonate.
- Susceptibility of Aspergillus to 5-fluorocytosine and amphotericin B alone and in combination.
- Targeted Treatment of Experimental Spinal Cord Glioma With Dual Gene-Engineered Human Neural Stem Cells.
- Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole.
- Zygomycosis caused by Cunninghamella bertholletiae: mycologic aspects.